JP Stock MarketDetailed Quotes

190A Chordia Therapeutics

Watchlist
  • 249
  • +26+11.66%
20min DelayMarket Closed Nov 22 15:30 JST
16.91BMarket Cap-7899P/E (Static)

Chordia Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Aug 31, 2022
(FY)Aug 31, 2021
Operating cash flow (Indirect Method)
Cash from operating activities
-195.32%-1.72B
-581.78M
Net profit before non-cash adjustment
-238.27%-1.78B
---525.21M
Total adjustment of non-cash items
-289.85%-141.67M
--74.62M
-Depreciation and amortization
349.57%3.15M
--700K
-Remuneration paid in stock
112.45%24.53M
--11.55M
-Other non-cash items
-371.49%-169.34M
--62.37M
Changes in working capital
252.57%200.16M
---131.19M
-Change in prepaid assets
190.89%156.71M
---172.42M
-Change in payables
12.74%45.33M
--40.21M
-Provision for loans, leases and other losses
-282.47%-1.87M
--1.03M
Dividends paid (cash flow from operating activities)
Dividends received (cash flow from operating activities)
Interest paid (cash flow from operating activities)
Interest received (cash flow from operating activities)
Tax refund paid
0.00%-1.9M
-1.9M
Other operating cash inflow (outflow)
-59.30%15.91M
39.09M
Operating cash flow
-212.92%-1.7B
---544.59M
Investing cash flow
Net PPE purchase and sale
-565.96%-8.74M
---1.31M
Net intangibles purchase and sale
-371.51%-4.8M
---1.02M
Net changes in other investments
-3,872.41%-1.15M
---29K
Investing cash flow
-522.71%-14.7M
---2.36M
Financing cash flow
Net common stock issuance
160.54%3.98B
--1.53B
Net other fund-raising expenses
----
--1K
Financing cash flow
160.54%3.98B
--1.53B
Net cash flow
Beginning cash position
96.05%2B
--1.02B
Current changes in cash
130.53%2.26B
--978.97M
Cash adjustments other than cash changes
0.00%-1K
---1K
End cash Position
112.94%4.25B
--2B
Free cash flow
-214.06%-1.72B
---546.92M
Currency Unit
JPY
JPY
Accounting Standards
NonUS-GAAP
NonUS-GAAP
(FY)Aug 31, 2022(FY)Aug 31, 2021
Operating cash flow (Indirect Method)
Cash from operating activities -195.32%-1.72B-581.78M
Net profit before non-cash adjustment -238.27%-1.78B---525.21M
Total adjustment of non-cash items -289.85%-141.67M--74.62M
-Depreciation and amortization 349.57%3.15M--700K
-Remuneration paid in stock 112.45%24.53M--11.55M
-Other non-cash items -371.49%-169.34M--62.37M
Changes in working capital 252.57%200.16M---131.19M
-Change in prepaid assets 190.89%156.71M---172.42M
-Change in payables 12.74%45.33M--40.21M
-Provision for loans, leases and other losses -282.47%-1.87M--1.03M
Dividends paid (cash flow from operating activities)
Dividends received (cash flow from operating activities)
Interest paid (cash flow from operating activities)
Interest received (cash flow from operating activities)
Tax refund paid 0.00%-1.9M-1.9M
Other operating cash inflow (outflow) -59.30%15.91M39.09M
Operating cash flow -212.92%-1.7B---544.59M
Investing cash flow
Net PPE purchase and sale -565.96%-8.74M---1.31M
Net intangibles purchase and sale -371.51%-4.8M---1.02M
Net changes in other investments -3,872.41%-1.15M---29K
Investing cash flow -522.71%-14.7M---2.36M
Financing cash flow
Net common stock issuance 160.54%3.98B--1.53B
Net other fund-raising expenses ------1K
Financing cash flow 160.54%3.98B--1.53B
Net cash flow
Beginning cash position 96.05%2B--1.02B
Current changes in cash 130.53%2.26B--978.97M
Cash adjustments other than cash changes 0.00%-1K---1K
End cash Position 112.94%4.25B--2B
Free cash flow -214.06%-1.72B---546.92M
Currency Unit JPYJPY
Accounting Standards NonUS-GAAPNonUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
JP
Overall
Symbol
Latest Price
% Chg

No Data